In recent years, transcatheter intervention techniques have emerged as a promising alternative for the closure of perimembranous ventricular septal defect (VSD). The advancements in trancatheter VSD ...

Chicago, IL - A nonrandomized trial of a new ventricular septal occluder designed specifically for the closure of defects that occur post-MI suggests that while mortality is still high following the ...

A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely undergo surgical repair at ...

Schaffhausen, Switzerland. Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained European CE Mark approval for its dedicated muscular ...

Percutaneous closure of symptomatic ventricular septal defects in children can be achieved with off-label use of an occluder device. A research letter published online November 7, 2012, ahead of print ...

Perimembranous ventricular septal defects (VSDs) involving the membranous septum and the adjoining muscular septum are the most common form of congenital heart defect. Traditional surgical repair ...

Muscular ventricular septal defects (mVSD) appearing together with other septal defects are frequently regarded as ‘concomitant’ pathologies, that nevertheless should be considered while the patient ...

A 52-year-old man was admitted to our center for the first episode of heart failure (HF). He had a history of mechanical aortic valve (AoV) implantation performed 13 years prior, subsequent Bentall ...

After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. Now, after 10 years of clinical ...

At 2-year follow-up, a septal occluder device was deemed safe and effective for transcatheter closure of atrial septal defects, according to new data published in Circulation: Cardiovascular ...